Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Recurso digital |
| Kieli: | englanti |
| Julkaistu: |
Zenodo
2025
|
| Linkit: | https://doi.org/10.5281/zenodo.17213632 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Sisällysluettelo:
- <p>Background: In Ayurveda, Sneha Pana (internal oleation with<br>medicated ghee) is often used as part of Panchakarma therapy.<br>Madhumeha, known as Type 2 Diabetes Mellitus (T2DM) in modern<br>medicine, is a metabolic disorder characterized by chronic<br>hyperglycemia due to insulin resistance. Over time, it is often<br>associated with various cardiovascular risk factors, including<br>hyperlipidemia. The altered lipid metabolism in T2DM patients<br>significantly increases the risk of atherosclerosis and cardiovascular<br>diseases, making it crucial to understand the interplay between<br>hyperlipidemia and Madhumeha. Concerns exist regarding the impact<br>of high ghee doses on cholesterol levels, particularly in patients with<br>metabolic disorders like Madhumeha (Type 2 Diabetes Mellitus). The<br>present study aims to clear this myth that escalating doses of Sneha<br>causes hyperlipidaemia in the patients of diabetes mellitus. Case<br>Presentation: A 55-year-old male with well-controlled Type 2<br>diabetes underwent a 6-day Sneha Pana regimen using escalating<br>doses of Indukanta Ghrita. The patient underwent a treatment protocol<br>that included Snehapana (medicated ghee administration) followed by Virechana (purgation<br>therapy) as part of an Ayurvedic intervention. Investigations revealed changes in various<br>biochemical parameters, including fasting blood sugar (FBS), lipid profile, and liver function<br>tests. This case highlights the importance of monitoring metabolic changes during traditional Ayurvedic therapies in patients with diabetes. Despite consuming a cumulative mL of ghee, post-therapy lipid profiles showed no significant changes in cholesterol, LDL, or triglycerides. Conclusion: This case suggests that large, short-term doses of Sneha, when used as part of Ayurvedic therapy for patients with Type 2 diabetes, do not lead to significant increases in blood cholesterol levels.</p>